| Crude HR | Adjusted HRa |
---|---|---|
General characteristics | ||
 Type 2 diabetes | 1.96 (1.79–2.14) | 1.60 (1.45–1.77) |
 Age | ||
  < 45 | 1.0 | 1.0 |
  45–64 | 1.23 (1.08–1.41) | 0.99 (0.87–1.14) |
  > 64 | 2.03 (1.77–2.32) | 1.32 (1.13–1.53) |
 Sex | ||
  Female | 1.0 | 1.0 |
  Male | 1.34 (1.23–1.46) | 1.42 (1.30–1.55) |
 Urbanization status | ||
  Urban area | 1.0 | 1.0 |
  Rural area | 1.38 (1.26–1.5) | 1.22 (1.12–1.34) |
 Comorbidities | ||
  Ischemic heart disease | 6.54 (6.01–7.12) | 4.60 (4.13–5.12) |
  Hypertensive disease | 2.18 (2–2.37) | 0.86 (0.75–0.99) |
  Rheumatic heart disease | 9.02 (7.77–10.47) | 2.41 (2.03–2.86) |
  Valvular heart disease | 6.68 (6.03–7.41) | 2.94 (2.59–3.34) |
  Congenital heart disease | 4.83 (3.48–6.72) | 2.03 (1.45–2.85) |
  Acute myocarditis | 22.75 (11.9–43.48) | 7.81 (3.91–15.6) |
  Obesity | 1.12 (0.84–1.51) | 1.06 (0.78–1.42) |
  Stroke | 1.43 (1.29–1.58) | 0.74 (0.66–0.82) |
  Hyperlipidemia | 1.14 (1.05–1.24) | 0.60 (0.55–0.66) |
 Antihypertensive medication | ||
  β-Blocker | 3.34 (3.06–3.63) | 1.70 (1.54–1.88) |
  ACEi | 3.47 (3.18–3.78) | 2.01 (1.80–2.25) |
  ARBs | 2.43 (2.23–2.64) | 1.26 (1.11–1.43) |